Journey Medical Corporation
DERM
$6.07
-$0.11-1.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.92M | 16.07M | 17.03M | 15.01M | 13.14M |
| Total Other Revenue | 40.00K | 13.00K | 606.00K | -- | -- |
| Total Revenue | 15.96M | 16.08M | 17.63M | 15.01M | 13.14M |
| Cost of Revenue | 6.22M | 5.44M | 5.76M | 4.94M | 4.79M |
| Gross Profit | 9.74M | 10.64M | 11.88M | 10.07M | 8.35M |
| SG&A Expenses | 10.11M | 9.86M | 12.05M | 11.88M | 10.57M |
| Depreciation & Amortization | 1.13M | 1.07M | 1.06M | 1.06M | 1.07M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.45M | 16.52M | 19.16M | 17.89M | 16.46M |
| Operating Income | -1.49M | -443.00K | -1.53M | -2.88M | -3.32M |
| Income Before Tax | -2.23M | -1.25M | -2.32M | -3.74M | -4.07M |
| Income Tax Expenses | -- | 0.00 | -- | 60.00K | -- |
| Earnings from Continuing Operations | -2.23M | -1.25M | -2.32M | -3.80M | -4.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.23M | -1.25M | -2.32M | -3.80M | -4.07M |
| EBIT | -1.49M | -443.00K | -1.53M | -2.88M | -3.32M |
| EBITDA | -366.00K | 622.00K | -465.00K | -1.81M | -2.26M |
| EPS Basic | -0.08 | -0.05 | -0.09 | -0.16 | -0.18 |
| Normalized Basic EPS | -0.05 | -0.03 | -0.06 | -0.10 | -0.11 |
| EPS Diluted | -0.08 | -0.05 | -0.09 | -0.16 | -0.18 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.06 | -0.10 | -0.11 |
| Average Basic Shares Outstanding | 27.31M | 27.11M | 24.96M | 23.29M | 22.61M |
| Average Diluted Shares Outstanding | 27.31M | 27.11M | 24.96M | 23.29M | 22.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |